-
Netlist adds new ITC complaint against Micron, Broadcom, Google, and Nvidia; “intends to rely on… Samsung” to prove domestic industry
Read more: Netlist adds new ITC complaint against Micron, Broadcom, Google, and Nvidia; “intends to rely on… Samsung” to prove domestic industryAfter settling with Netlist last month, Samsung agreed to provide “certain information… to use in future ITC actions against third parties”.
-
Novo Nordisk signs GLP-1 licensing agreement with China’s Hengrui Pharma
Read more: Novo Nordisk signs GLP-1 licensing agreement with China’s Hengrui PharmaNovo Nordisk and Hengrui Pharma’s agreement, subject to antitrust approval, will allow Novo to obtain exclusive rights to develop, manufacture, and commercialize HRS-1596 globally, excluding mainland China, Hong Kong, Macao, and Taiwan.
-
Adeia appoints former Arm executive as CEO, with licensing into new verticals at the top of her to-do list
Read more: Adeia appoints former Arm executive as CEO, with licensing into new verticals at the top of her to-do listDipti Vachani, who also worked at Intel and Texas Instruments, was previously focused on semiconductor licensing for the automotive and IoT segments.
-
Via annual Bridge Summit to focus on AI licensing
Read more: Via annual Bridge Summit to focus on AI licensingVia Licensing Alliance’s fourth-ever annual Bridge Summit, due to take place next week, will feature AI infrastructure and data center licensing discussions throughout its conference, as well as licensor meetings dedicated to its newly launched DRAM pool.
-

Roborock turns the tables on Ecovacs: first UPC suit escalates patent war across U.S., Europe, China
Read more: Roborock turns the tables on Ecovacs: first UPC suit escalates patent war across U.S., Europe, ChinaRoborock has filed its first UPC infringement suit against Ecovacs, turning their UPC dispute into a two-way fight. Following two reported German injunction wins and the reversal of Ecovacs’ inspection order, the new Munich action escalates a patent battle between Chinese rivals spanning China, Europe and the U.S.
-
UPC Roundup (1 week): CoA addresses pre-grant non-infringement actions; Munich LD revokes third Maxell patent; and more
Read more: UPC Roundup (1 week): CoA addresses pre-grant non-infringement actions; Munich LD revokes third Maxell patent; and moreThis is a summary of developments in and around the UPC in the calendar week of September 21, 2026.
-
Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible
Read more: Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possibleIt will not be easy to defend this record patent damages verdict, given not only its outsized amount but also the deficiencies of the record that Apple has already alleged.



